舒普深联合左氧氟沙星治疗哮喘并发肺部感染的疗效分析

Analysis of the Therapeutic Effect of Shu Pu Shen Combined with Levofloxacin in the Treatment of Pulmonary Infection in Patients with Asthma

目的:研究舒普深联合左氧氟沙星治疗哮喘并发肺部感染的临床疗效。方法:选取2012年6月到2016年6月来我院治疗的哮喘合并肺部感染患者80例,按照患者入院时间将患者随机分为观察组(n=40)和对照组(n=40)。对照组采用舒普深治疗,观察组采用舒普深和左氧氟沙星联合治疗,两组患者均治疗2周,观察比较两组患者的治疗疗效、病原菌清除率以及肺功能的恢复情况。结果:观察组患者的总效率、病原菌清除率均较对照组总有效率显著提高,差异具有统计学意义(P<0.05)。与治疗前相比,两组患者治疗后的肺功能指标均显著提高,且观察组患者的肺功能指标较治疗组改善更显著。结论:舒普深联合左氧氟沙星治疗哮喘并发肺部感染临床疗效显著,可显著改善患者肺功能。

Objective： To explore the therapeutic effect of Shu Pu Shen combined with levofloxacin in the treatment of pulmonary infection in patients with asthma. Methods： 80 patients with asthma complicated with pulmonary infection from June 2012 to June 2016 in our hospital were selected. They were randomly and equally divided into the observation group （n=40） and the control group（n=40）. The control group was treated with Shu Pu Shen, and the treatment group was treated with Shu Pu Shen combined with levofloxacin. The curative effect, pathogenic bacteria clearance rate and recovery of pulmonary function were compared between the two groups after treatment for 2 weeks. Results： Compared with the control group, the total efficiency and pathogenic bacteria clearance rate in the observation group were significantly higher than those of the control group （P〈0.05）. The hmg function indexes of both groups after treatment were significantly improved compared with those before treatment, and the lung function indexes of observation group were significantly better than those in the control group. Conclusion： Shu Pu Shen and levofloxacin had good clinical effect on asthma combined with pulmonary infection, which could significantly improve the lung function.